- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Results
12
12 companies
WuXi XDC Cayman
Market Cap: HK$72.0b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$57.25
7D
12.7%
1Y
28.9%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$41.5b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$57.25
7D
17.8%
1Y
284.2%
XtalPi Holdings
Market Cap: HK$40.0b
An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.
2228
HK$9.29
7D
4.1%
1Y
57.7%
RemeGen
Market Cap: HK$72.4b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$98.85
7D
13.2%
1Y
317.1%
CanSino Biologics
Market Cap: HK$13.2b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$32.50
7D
2.7%
1Y
-2.7%
Innovent Biologics
Market Cap: HK$149.4b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$86.10
7D
11.1%
1Y
84.8%
JBM (Healthcare)
Market Cap: HK$2.2b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.64
7D
2.7%
1Y
47.5%
Luye Pharma Group
Market Cap: HK$9.7b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.42
7D
4.3%
1Y
12.6%
SSY Group
Market Cap: HK$7.3b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.51
7D
5.0%
1Y
-22.0%
Viva Biotech Holdings
Market Cap: HK$4.2b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.99
7D
7.6%
1Y
16.4%
China Medical System Holdings
Market Cap: HK$32.8b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.54
7D
3.5%
1Y
81.7%
Grand Pharmaceutical Group
Market Cap: HK$25.1b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$7.16
7D
9.3%
1Y
18.7%